ArticleFrontiers in immunology2026
A standardized single-tube 17-color spectral flow cytometry workflow for integrated immunophenotyping of human PBMCs and mixed co-culture systems.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Special Issue "Flow Cytometry: Applications and Challenges".International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a standardized single-tube 17-color spectral flow cytometry workflow for integrated immunophenotyping of human peripheral blood mononuclear cells (PBMCs). This Methods Article describes a quality-controlled protocol that combines lineage identification with activation, regulatory, and checkpoint-associated markers within a reproducible quality-control framework. Panel optimization incorporated spectral similarity index (SI) and spillover spreading matrix (SSM) metrics, antigen-density-guided fluorochrome assignment, systematic antibody titration, fluorescence-minus-one (FMO)-anchored gating, autofluorescence extraction, and longitudinal internal controls. The workflow supports robust immunophenotyping of PBMCs across experiments when appropriate viability gating, autofluorescence correction, and quality-control checkpoints are applied, and enables CD45-based compartment discrimination in mixed immune-tumor co-culture systems. Single-tube multiparameter staining facilitates unsupervised cluster analysis and supports identification of expected and potentially underappreciated immune subsets. The manuscript emphasizes methodological transparency, reproducibility strategies, and principles supporting panel transferability rather than hypothesis-driven biological discovery. This work provides a practical and transferable framework for high-dimensional immune monitoring in translational and preclinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.